On Monday shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) closed at $14.20. Roth Capital reiterated their buy rating on shares of Concert Pharmaceuticals (NASDAQ:CNCE) in a research note released on Tuesday morning.
The Procter & Gamble Company (NYSE:PG) in last trading activity moved down -0.38% to close at $80.74. Company weekly performance is 0.59% while its quarterly performance stands at -4.80%. The Procter & Gamble Company (NYSE:PG) is -12.70% away from its 52 week high. Procter & Gamble Co. (NYSE:PG) will seek to consolidate all of its giant North American paid media buying and planning account — now handled by at least four incumbents — with a single shop and expects to have a decision by fall. News of the review was reported on Friday.
On last trading day SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) moved down -4.76% to close at $1.40. Its volatility for the week is 11.75% while volatility for the month is 8.12%. SPU’s sales growth for past 5 years was 10.90% and its EPS growth for past 5 years was -8.20%. SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) monthly performance is 13.82%. SkyPeople Fruit Juice Inc (NASDAQ:SPU) on Friday reported first-quarter net income of $1.5 million or $0.06 a share compared with $0.5 million or $0.02 a share a year ago. Revenues for the quarter jumped 41% to $16.6 million from $11.8 million a year ago. This was due increased demand for fruit juice beverages, concentrated pear and kiwifruit juices as well as kiwi puree.
On last trading day Pandora Media Inc (NYSE:P) remains unchanged to close at $18.31. Its volatility for the week is 3.37% while volatility for the month is 4.05%. P’s sales growth for past 5 years was 75.60% and its EPS growth for past 5 years was 0.00%. Pandora Media Inc (NYSE:P) monthly performance is 4.69%. Pandora Media Inc (NYSE:P) declared that the company’s Chief Financial Officer, Mike Herring, will present at the J.P. Morgan Global Technology, Media and Telecom Conference in Boston, MA. Mr. Herring will engage in a fireside chat on Tuesday, May 19, 2015 at 6:20 a.m. PT / 9:20 a.m. ET.
Merck & Co. Inc. (NYSE:MRK) has 0.04% insider ownership while its institutional ownership stands at 75.30%. In last trading activity company’s stock closed at $60.01. Merck & Co. Inc. (NYSE:MRK) announced that new investigational data in 10 different types of cancer from the company’s immuno-oncology development program evaluating its anti-PD-1 therapy, KEYTRUDA® , will be presented at the 51st Annual Meeting of the American Society of Clinical Oncology in Chicago, May 29 – June 2, 2015.